Biomind Labs Inc - ESG Rating & Company Profile powered by AI
The assessment of Biomind Labs Inc employs intelligence from across the internet and also from public disclosures by Biomind Labs Inc. The ESG score for Biomind Labs Inc represents its transparency towards the United Nations SDGs. Alternative corporations in the scoring peer group for Biomind Labs Inc are shown.
Biomind Labs Inc in the Investment Management & Fund Operators industry gained a UN SDG ESG Transparency Score of 0.9; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.7.
0.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Centuria Capital Ltd | 8.0 | High |
| 1 | Ceylon Guardian Investment Trust PLC | 8.0 | High |
| ... | ... | ... | |
| 549 | Tribeca Global Natural Resources Ltd | 1.1 | Low |
| 549 | Western Financial Corp | 1.1 | Low |
| 570 | Biomind Labs Inc | 0.9 | Low |
| 570 | Cambria Africa PLC | 0.9 | Low |
| 570 | Capital Southwest Corp | 0.9 | Low |
| 650 | Zero2ipo Holdings Inc. | 0.0 | Low |
| 650 | advantec Beteiligungskapital AG & Co KGaA | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Biomind Labs Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Biomind Labs Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Biomind Labs Inc report the average age of the workforce?
Sign up for free to unlockDoes Biomind Labs Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Biomind Labs Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Biomind Labs Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Biomind Labs Inc offer flexible work?
Sign up for free to unlockDoes Biomind Labs Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Biomind Labs Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Biomind Labs Inc conduct supply chain audits?
Sign up for free to unlockDoes Biomind Labs Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Biomind Labs Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Biomind Labs Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Biomind Labs Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Biomind Labs Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Biomind Labs Inc disclose water use targets?
Sign up for free to unlockDoes Biomind Labs Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Biomind Labs Inc have a product recall in the last two years?
Sign up for free to unlockDoes Biomind Labs Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Biomind Labs Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Biomind Labs Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Biomind Labs Inc disclose parental leave metrics?
Sign up for free to unlockDoes Biomind Labs Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Biomind Labs Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Biomind Labs Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Biomind Labs Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Biomind Labs Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Biomind Labs Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Biomind Labs Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Biomind Labs Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Biomind Labs Inc disclose its waste policy?
Sign up for free to unlockDoes Biomind Labs Inc report according to TCFD requirements?
Sign up for free to unlockDoes Biomind Labs Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Biomind Labs Inc disclose energy use targets?
Sign up for free to unlockDoes Biomind Labs Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Biomind Labs Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Biomind Labs Inc
These potential risks are based on the size, segment and geographies of the company.
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammation, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.